^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    GENE:

    SLC25A21-AS1 (SLC25A21 Antisense RNA 1)

    i
    Other names: SLC25A21-AS1, SLC25A21 Antisense RNA 1, HSALNG0100684
    Associations

    News

    Trials
    almost3years
    M6A-BASED BIOMARKERS FOR RISK-STRATIFICATION AND RESPONSE PREDICTION TO ADJUVANT CHEMOTHERAPY IN STAGE II-III COLORECTAL CANCER (DDW 2023)
    We established a novel m6A-related signature that can robustly risk stratifying stage II and III CRC patients into low and high-risk groups for their response to adjuvant chemotherapy, which has important clinical implications for personalized management of patients suffering from this malignancy.
    Clinical
    |
    SERPINA3 (Serpin Family A Member 3) • SLC25A21 (Solute Carrier Family 25 Member 21) • SLC25A21-AS1 (SLC25A21 Antisense RNA 1)